GAST and gastrointestinal stromal tumor: We chose the minigastrin analogue MG11 as a model peptide, since gastrin is an interesting peptide for both diagnostic and therapeutic applications in rare malignant diseases (MTC, GIST) [17–19], and this particular peptide was already used in combination with a number of alternative chelating systems.